Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 1, 2012, Pages 231-237

  Trakul, Nicholas ^a   Chang, Christine N ^a   Harris, Jeremy ^a   Chapman, Christopher ^a,c   Rao, Aarti ^a,d   Shen, John ^a,e   Quinlan Davidson, Sean ^a,f   Filion, Edith J ^a,g   Wakelee, Heather A ^a,b   Colevas, A Dimitrios ^a,b   Whyte, Richard I ^a,b   Dieterich, Sonja ^a   Maxim, Peter G ^a   Hristov, Dimitre ^a   Tran, Phuoc ^a,h   Le, Quynh Thu ^a   Loo Jr , Billy W ^a   Diehn, Maximilian ^a  

^a STANFORD CANCER INSTITUTE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MCMASTER UNIVERSITY   (Canada)

^g CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biologically effective dose; Lung cancer; Metastases; Stereotactic ablative radiotherapy; Stereotactic body radiation therapy

Indexed keywords

BIOLOGICAL ORGANS; PATHOLOGY; RADIOTHERAPY; TOXICITY;

BIOLOGICALLY EFFECTIVE DOSE; LUNG CANCER; METASTASES; STEREOTACTIC ABLATIVE RADIOTHERAPIES; STEREOTACTIC BODY RADIATION THERAPY;

TUMORS;

ADULT; AGED; CANCER CONTROL; CANCER SURVIVAL; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; REVIEW; STEREOTACTIC ABLATIVE RADIOTHERAPY; STEREOTACTIC PROCEDURE; TUMOR VOLUME;

EID: 84865694578     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.10.071     Document Type: Article

References (20)

1. Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases. The International Registry of Lung Metastases J Thorac Cardiovasc Surg 113 1997 37 49
2. R.D. Timmerman, C.S. Bizekis, and H.I. Pass Local surgical, ablative, and radiation treatment of metastases CA Cancer J Clin 59 2009 145 170
3. M. Hadziahmetovic, B.W. Loo, and R.D. Timmerman Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer: Updates of radiobiology, techniques, and clinical outcomes Discov Med 9 2010 411 417
4. T.D. Crabtree, C.E. Denlinger, and B.F. Meyers Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer J Thorac Cardiovasc Surg 140 2010 377 386
5. M. Das, M.H. Abdelmaksoud, and B.W. Loo Jr. Alternatives to surgery for early stage non-small cell lung cancer-ready for prime time? Curr Treat Options Oncol 11 2010 24 35
6. R. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
7. K.E. Rusthoven, B.D. Kavanagh, and S.H. Burri Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases J Clin Oncol 27 2009 1579 1584
8. J. Wulf, K. Baier, and G. Mueller Dose-response in stereotactic irradiation of lung tumors Radiother Oncol 77 2005 83 87
9. H. Onishi, H. Shirato, and Y. Nagata Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 2007 S94 S100
10. R.D. Timmerman, C. Park, and B.D. Kavanagh The North American experience with stereotactic body radiation therapy in non-small cell lung cancer J Thorac Oncol 2 2007 S101 S112
11. Q.T. Le, B.W. Loo, and A. Ho Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors J Thorac Oncol 1 2006 802 809
12. J.M. Brown, M. Diehn, and B.W. Loo Jr. Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer Int J Radiat Oncol Biol Phys 78 2010 323 327
13. J.Y. Chang, P.A. Balter, and L. Dong Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer Int J Radiat Oncol Biol Phys 72 2008 967 971
14. J.C. Hong, Y. Yu, and A.K. Rao High retention and safety of percutaneously implanted endovascular embolization coils as fiducial markers for image-guided stereotactic ablative radiotherapy of pulmonary tumors Int J Radiat Oncol Biol Phys 81 2010 85 90
15. R. Onimaru, M. Fujino, and K. Yamazaki Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy Int J Radiat Oncol Biol Phys 70 2008 374 381
16. F. Zimmermann, J. Wulf, and I. Lax Stereotactic body radiation therapy for early non-small cell lung cancer Front Radiat Ther Oncol 42 2010 94 114
17. J.D. Bradley, I. El Naqa, and R.E. Drzymala Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: The pattern of failure is distant Int J Radiat Oncol Biol Phys 77 2010 1146 1150
18. M. Werner-Wasik, R.S. Swann, and J. Bradley Increasing tumor volume is predictive of poor overall and progression-free survival: Secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 2008 385 390
19. C. Park, L. Papiez, and S. Zhang Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy Int J Radiat Oncol Biol Phys 70 2008 847 852
20. F. Baba, Y. Shibamoto, and H. Ogino Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size Radiat Oncol 5 2010 81